SpineJack® Versus Conservative Treatment Study (SPICO Study)
Prospective Multicenter Randomized Study Comparing Two Standard Treatments: SpineJack® System and Conservative Orthopedic Management in Acute Traumatic Vertebral Fractures Types A1 and A3.1 According to the Magerl Classification
Sponsor: Statitec
This NA trial investigates Back Injuries and Spinal Fractures and is currently completed. Statitec leads this study, which shows 12 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2023 — Jul 2024 [monthly]
Completed NA
-
Jul 2022 — May 2023 [monthly]
Completed NA
-
Dec 2021 — Jul 2022 [monthly]
Completed NA
Status: Unknown Status → Completed
▶ Show 7 earlier versions
-
Feb 2021 — Dec 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Feb 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jul 2018 — Feb 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Statitec
- Vexim SA
For direct contact, visit the study record on ClinicalTrials.gov .